Source: Irish Tech News

OncoMark: OncoMark Secures €2.1 Million Investment to Commercialise New Diagnostic Test for Breast Cancer

OncoMark, a University College Dublin (UCD) spin-out company, today announced that is has secured €2.1 million in funding. The funding round included; Kernel Capital, through the Bank of Ireland Kernel Capital Venture Funds, the Irrus Investments syndicate, the Galway HBAN MedTech syndicate, private investors and Enterprise Ireland. OncoMark is focused on the development of novel [...]

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Desmond O 'Leary's photo - CEO of OncoMark

CEO

Desmond O 'Leary

CEO Approval Rating

90/100

Read more